O VER the past 20 years numerous studies have demonstrated the presence of a natriuretic factor in mammalian blood and urine that is activated or released by volume expansion.
1 -2 Recent evidence suggests that this factor is an inhibitor of Na, K activated adenosine triphosphatase (Na, K-ATPase),-^ which probably interacts with the ouabain binding site on the enzyme. 6 -7 Theoretical considerations and experimental evidence suggest that inhibition of Na, K-ATPase can increase the contractile force of vascular smooth muscle. 9 " 1 -1 Since this action may elevate peripheral vascular resistance and induce a rise in blood pressure," l3 a link between the natriuretic factor and the etiological process of some forms of hypertension was postulated. 14 
"
17 This hypothesis is supported by the identification of a circulating endogenous inhibitor of the Na, KATPase in hypertensive animals 14 " 16 and humans. 171 * " 23 and from toad skin and blood, 24 " we thought it reasonable to assume that the natriuretic substance and the ouabainlike compound are identical.
The availability of the Sabra hypertension prone rats (SBH) and Sabra normotensive rats (SBN) prompted a search for a circulating ouabainlike inhibitor of the Na, K-ATPase in this model. The two strains initially were selected from the Hebrew University Sabra rat for their respective sensitivity or resistance to deoxycorticosterone acetate salt hypertension. 26 (For a detailed description of the main characteristics of these animals, see refs. 27 and 28.) We also sought to determine whether the disparate susceptibility to hypertension of these rats could be related to the presence of a circulating Na, K-ATPase inhibitor in the plasma. VOL 7, No 5, SEPTEMBER-OCTOBER 1985 Materials and Methods Partial Purification of Ouabainlike Compound Studies were performed on male SBH and SBN, aged 2 to 5 months, maintained since weaning on regular laboratory chow (Ambar Food Mills, Hadera, Israel) containing 0.6 to 0.8% sodium and tap water. The blood pressure (mean ± SE) measured in prewarmed, unanesthetized animals was 151 ± 2.4 and 127 ± 1.3 mm Hg respectively (p < 0.01). The animals were bled from the abdominal aorta under ether anesthesia, the plasma of 3 to 10 rats was pooled, and methanol was added (v/v). Proteins were precipitated by high speed centrifugation (100,000 g), and the supernatant decanted. The methanol was evaporated, and the samples were centrifuged again at 100,000 g. The aqueous supernatant was separated and lyophilized. The residue was dissolved in 1.2 ml of methanol, and aliquots of 20 to 200 ixl were fractionated by high-performance liquid chromatography (model 985, Tracor Instruments, Austin, TX, USA) using an Alltech amino column. The column had been equilibrated with 90% acetonitrile and eluted with a linear 90% to 20% acetonitrile gradient in 40 minutes at a flow rate of 1 ml/min. The elution of the compounds was monitored at 300 nm with a Tracor 970A detector. Fractions of 2 ml were collected and evaporated, and the residue was dissolved in 1 ml of distilled water. Aliquots from this solution were used for measurements of biological activity.
The method used for the extraction and partial purification of the OLC is highly reproducible. When aliquots of pooled plasma extract were processed by this method values of OLC obtained did not vary by more than 5%.
Measurements of
3 H-Ouabain Binding to Rat Brain Synaptosomes Rat brain synaptosomes were prepared as previously described. 21 Binding of-'H-ouabain was assayed by a conventional filtration technique. The reaction mixture (500 /AI final volume) contained the following constituents (in final concentrations): 50 mM tris(hydroxymethyl) aminomethane hydrochloride buffer (pH 7.4), 0.5 mM ethylenediaminetetraacetic acid, 80 mM NaCl, 4 mM MgSO 4 , 2 mM adenosine triphosphate (Tris, vanadium-free; Sigma Chemical Co., St. Louis, MO, USA), 32 nM ['HJouabain (19.5 Ci/ mmol; New England Nuclear Corp., Boston, MA, USA), and other additions as indicated. Reactions were initiated by the addition of 200 /xl of a crude synaptosomal fraction, which resulted in a final protein concentration of 200 /xg per reaction. Binding equilibrium was achieved after incubation for 1 hour at 37 °C. The reactions were terminated by adding 3 ml of ice-cold 50 mM Tris-hydrochloride (pH 7.4), and the suspension was filtrated over Whatman GF/B filters (Whatman, Inc., Clifton, NJ, USA). Filters were washed three times with 3 ml of the same Tris buffer, dried, and assayed for radioactivity in a Packard liquid scintillation counter (Packard Instrument Co., Inc., Rockville, MD, USA) at a counting efficiency of approximately 35%. Specific binding was calculated by subtracting the binding observed in the presence of 100 /u,M unlabeled ouabain from that observed in the absence of unlabeled ouabain. Specific binding represented 93% of the total binding under control conditions. Binding of [ 3 H]ouabain was a linear function of membrane protein concentration in the range of 20 to 1000 fJLg per assay. Binding to the filters was negligible when synaptosomes were omitted from the incubation.
Measurements of Na, K Activated Adenosine Triphosphatase Activity
Enzyme activity in rat brain microsomal fraction was measured by the colorimetric determination of inorganic phosphate 29 after the incubation of synaptosomes (200 fig of protein per reaction) at 37 °C in a solution containing (in final concentrations): 54 mM Tris-hydrochloride (pH 7.4), 100 mM NaCl, 20 mM KG, 4 mM MgCl 2 , and 4 mM adenosine triphosphate (Tris, vanadium-free). The adenosine triphosphate was added after a 10-minute preincubation to initiate the reaction. Reactions were terminated by adding 5% tricarboxylic acid, and the precipitate was removed by centrifugation. The Na, K-independent ATPase activity was determined by omitting Na + and K + from the reaction mixture or by adding I mM ouabain to the complete assay mixture.
Measurements of Cardiac Muscle Contraction
Tension recordings were done from rat atrial strips placed in a 2-ml chamber and perfused with control solution containing 140 mM NaCl, 5.4 mM K G , 12 mM NaHCO,, 2 mM CaCl,, 1 mM MgCl 2 , 0.4 mM Na,HPO 4 , and 5 mM glucose, continuously bubbled with 95% O 2 , 5% CO 2 with a pH of 7.4 at 36 °C. One end was attached to an AKERS force transducer (Aksjeselskapet mikro-elektronikk, Horten, Norway) for measuring the strength of contraction. Constant stimulation was applied at a rate of 0.5 Hz, and twitch magnitude was monitored on a pen recorder and oscilloscope and stored on magnetic tape.
Results
An example of a chromatographic pattern is shown in Figure I . The biological activity (i.e., inhibition of 'H-ouabain binding) was found in the peaks at a retention time of 12 to 20 minutes with a maximum in the fraction at 15 minutes.
In the first set of experiments approximately 300 ml of pooled plasma from SBH was used. The OLC was extracted and partially purified as described in Methods. The material present in the fractions with a retention time of 12 to 20 minutes was collected, and aliquots were tested. As can be seen in Figure 2 , the endogenous material was capable of inhibiting both ouabain binding and Na, K-ATPase activity. Both effects appeared to depend on the concentration of the material in the assay. Like ouabain, the endogenous compound inhibited Na, K-ATPase activity at concentrations almost 100 times higher than those need- Figure 2) . ed to inhibit 3 H-ouabain binding. 8 Furthermore, at concentrations that caused 50% inhibition of Na, K-ATPase activity, no change in Mg-ATPase activity was detected.
Since cardiac glycosides increase the contractile force of heart muscle, demonstration of such an effect by the endogenous compound might provide further indication of its ouabainlike activity. As can be seen in Figure 3 , the addition of the partially purified material to a preparation of rat atrial muscle resulted in a marked increase (30%) in the contractile force that was completely reversible on washout. In two other experiments, 20 ixM ouabain resulted in an increase in the force of contraction by 70% and 100% (data not shown). The results of this set of experiments are consistent with the contention that the endogenous compound is ouabainlike in nature.
In a second set of experiments, the compound partially purified from plasma of several groups of SBH and SBN (with the use of the chromatographic system described in Methods) was compared for its ability to inhibit J H-ouabain binding. To avoid possible bias the tests were carried out on coded samples. Each specimen was tested at least twice and was found to vary by no more than 5%. The K level in all the tested fractions was negligible and therefore could not have affected ouabain binding.
As shown in Table 1 , the plasma levels of the J Houabain displacing material were extremely variable, averaging 2543 zh 1140 and 698 ± 199 pmol/ml of plasma (mean ± SEM) for SBN and SBH respectively. The ability of the compound to inhibit Na, K-ATPase 
698±199
The concentration of the compound in pooled plasma of 3 to 10 rats was estimated by testing the ability of extracted and separated material to inhibit 3 H-ouabain binding to rat brain synaptosomes. Each experiment represents a different pool. The difference in the concentration of the compound between SBH and SBN was not statistically significant. activity was not assessed in this study since, as previously stated, large volumes of plasma are needed for this assay.
Discussion
This study provides evidence for the presence of an endogenous inhibitor of Na, K-ATPase in the plasma of hypertension prone Sabra rats. The compound also appears to be capable of inhibiting 3 H-ouabain binding to its specific receptors on the plasma membrane. These findings indicate that the inhibition of the enzyme activity by the endogenous compound is due to its interaction with the digitalis binding sites of Na, KATPase.
In addition, our results demonstrate that the endogenous plasma compound, like digitalis, increases the contractile force of heart muscle. The increase in the positive inotropic effect amounted to 30% and was observed at a concentration of 0.5 /xM ouabain equivalents. The concentration of the OLC was approximated from the binding experiments under the assumption that the endogenous material and ouabain have the same affinity for their common binding site. Evidently, this is a crude estimation, and the actual plasma concentration of the material remains to be determined. Moreover, it is premature to compare the relative potencies of OLC to cardiac glycosides in their ionotropic effect. Atrial contractility may be influenced by other factors including local release of endogenous catecholamines and alterations in calcium metabolism. However, the observation that the same material that inhibited [ 3 H]ouabain binding and Na, KATPase activity also increased the contractile force of the myocardium strongly supports the contention that the endogenous compound is ouabainlike in nature.
The finding of an increase in the contractile force of heart muscle by material isolated from rat blood is in accordance with our recent report of a similar effect of compounds partially purified from toad skin and sheep brain. 30 Due to the small amount of OLC obtained from the rat plasma, we were unable to characterize the inotropic effect with respect to its dose dependence, sensitivity to a-adrenergic and /3-adrenergic blockers, extracellular ion concentration, and rate of stimulation. It is noteworthy, however, that the compounds partially purified from toad skin, 30 human cerebrospinal fluid, 31 and sheep brain 30 also increase the contractile force of heart muscle. The inotropic effect of the toad skin OLC was characterized in detail and was found to be almost identical to that obtained with cardiac glycosides (unpublished observation). Since all the compounds in these studies were separated using almost identical methods, the similarity of the toad skin compound to digitalis may also apply to the OLCs obtained from other sources. The presence of such compounds in mammalian blood raises the possibility that they might participate in the regulation of cardiac contractility under physiological conditions.
In spite of extensive investigation, the structure of these compounds is unknown. Partial characterization of the OLC obtained from different sources 14 
"
24 indicates that it is of low molecular weight (< 1000 daltons). The elucidation of its structure is clearly an important challenge, and studies are in progress to achieve this goal.
In the present study, while the difference in blood pressure between SBH and SBN was highly significant, no difference in OLC levels was detected. The moderate difference in systolic blood pressure reported here was invariably associated with a measurable degree of cardiac hypertrophy in the SBH. For example, the heart weight of adult rats corrected for 100 g body weight averaged 268 ± 8 mg in SBH compared with 247 ± 4mginSBN(/><0.01). Previous studies have shown that the two strains are dissimilar in several other physiological parameters. For example, compared with SBN, the SBH are heavier, have lower fluid intake and urinary output, and have markedly elevated urine osmolality. 28 These important differences have no apparent effect on the activity of the renal Na, KATPase, which is comparable in isolated nephron segments. 32 The lack of difference in OLC levels (as estimated by inhibition of ouabain binding in rat brain synaptosomes), in conjunction with results in isolated nephron, does not suggest a correlation between high blood pressure and alterations in pump activity in the SBH. These results are at variance with two recent studies in humans in which a significant difference between hypertensive and normotensive subjects was observed. 17 -l8 The large variation of OLC level in our rats may reflect individual variability of undefined physiological parameters that affect the metabolism of the compound. Alternatively, it may be due to technical prob-lems such as variation in the recovery of the chromatographic system used for the separation of the compound. Another factor could be the time interval from the extraction of the material until its determination, which ranged from 1 week up to 3 months in this study. Since the long-term stability of the compound is still unknown, the length of storage may have affected the results.
Finally, since the OLC was determined on deproteinized plasmas, the effect of denaturation of plasma proteins should be considered. It is possible that a large portion of the compound, like steroid hormones, is bound to plasma proteins. Assuming that only the free fraction is physiologically active and relevant to hypertension, a putative strain difference would be obliterated by the current method in which the total plasma OLC values were determined.
